ETXPF Projected Dividend Yield
Ord/E-Therapeutics PLC ( OTCBB : ETXPF )E-Therapeutics is engaged in computational drug discovery business. Co. constructs and analyse biological networks using its computer-based platform to give insight into disease mechanisms. Co.'s proprietary in silico platform incorporates data and a suite of computational tools that employ analytical techniques, including machine learning. Co. focuses on two Network-Driven Drug Discovery (NDD) derived assets in the immuno-oncology area: Tryptophan Catabolism and Immune Checkpoint Modulation. Co. also has commercial collaborations program. Co. is using its NDD approach to identify intervention strategies, biological pathways and compounds for its partner, Novo Nordisk for Type-2 diabetes. 20 YEAR PERFORMANCE RESULTS |
ETXPF Dividend History Detail ETXPF Dividend News ETXPF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |